PP
CBIO

PDT Partners’s Crescent Biopharma CBIO Stock Holding History

PDT Partners’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-823
Closed -$191K – 820
2021
Q2 		$191K Hold
823
– – 0.01% 708
2021
Q1 		$248K Buy
823
+307
+59% +$110K 0.02% 658
2020
Q4 		$194K Buy
+516
New +$181K 0.01% 613
2020
Q3 		– Sell
-419
Closed -$158K – 774
2020
Q2 		$158K Hold
419
– – 0.01% 607
2020
Q1 		$96K Sell
419
-2
-0.5% -$764 0.01% 615
2019
Q4 		$222K Buy
+421
New +$228K 0.01% 622

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return